Screener
Harrow HROW Compounding — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Harrow in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Harrow’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-022254
| Line item | Branded | Compounding | Consolidated |
|---|---|---|---|
| Gross profit | 19,750,000 | 7,295,000 | 27,045,000 |
| Operating expenses | |||
| Selling, general and administrative | 25,759,000 | 6,742,000 | 32,501,000 |
| Research and development | 5,621,000 | 210,000 | 5,831,000 |
| Segment contribution | $(11,630,000) | $343,000 | (11,287,000) |
| Corporate | - | - | 10,729,000 |
| Research and development | 64,000 | ||
| Loss from operations | $(22,080,000) |
Item 1. Financial Statements (unaudited) Item
FAQ
- What is Harrow's compounding — operating income?
- Harrow (HROW) reported compounding — operating income of $343K in Q1 2026.
- What does compounding — operating income mean?
- This metric measures the profitability of the compounding segment after accounting for both the direct costs of production and all associated operating expenses. It serves as the definitive indicator of the segment's operational health and its contribution to the overall company bottom line. Investors use this to evaluate the segment's ability to generate sustainable returns on invested capital.
Ask your AI about Harrow's compounding — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude